naltrexone has been researched along with thyroxine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bauman, M; Bullen, BA; Evans, WJ; Henley, K; McArthur, JW; Pehrson, J; Skrinar, GS; Turnbull, BA; Turner, A | 1 |
| Christakopoulou, I; Ilias, I; Kakoulas, I; Katsadoros, K | 1 |
| Dement'eva, TIu; Grigor'eva, TA; Obut, TA; Saryg, SK | 1 |
| Dement'eva, TIu; Erdynieva, TA; Obut, TA; Saryg, SK | 1 |
| Brown, WA; Man Lee, CC; Oldfield, BJ; Stefanidis, A | 1 |
| Raknes, G; Småbrekke, L | 1 |
2 review(s) available for naltrexone and thyroxine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for naltrexone and thyroxine
| Article | Year |
|---|---|
Nalmefene enhances LH secretion in a proportion of oligo-amenorrheic athletes.
Topics: Adult; Amenorrhea; Analysis of Variance; Androstenedione; Dehydroepiandrosterone; Estradiol; Female; Humans; Luteinizing Hormone; Menstruation; Naltrexone; Narcotic Antagonists; Oligomenorrhea; Physical Education and Training; Pituitary Gland; Progesterone; Sports; Substance Withdrawal Syndrome; Thyrotropin; Thyroxine; Time Factors; Vagina | 1993 |
7 other study(ies) available for naltrexone and thyroxine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Thyroid function of former opioid addicts on naltrexone treatment.
Topics: Adult; Female; Heroin Dependence; Humans; Interleukin-6; Male; Naltrexone; Narcotic Antagonists; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2001 |
[The denydroepiandrosterone sulfate thyroid activation through the mu-opioid receptors under cold influences].
Topics: Adjuvants, Immunologic; Animals; Cold Temperature; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid, mu; Thyroid Gland; Thyroxine; Triiodothyronine | 2008 |
[Changes in the thyroid activity and influence of dehydroepiandrosterone-sulfate under the cold and not cold influence].
Topics: Animals; Cold Temperature; Dehydroepiandrosterone Sulfate; Male; Naltrexone; Rats; Rats, Wistar; Receptors, Opioid, mu; Stress, Physiological; Thyroid Gland; Thyroxine; Triiodothyronine | 2009 |
Improving efficacy of the adjustable gastric band: studies of the use of adjuvant approaches in a rodent model.
Topics: Adipose Tissue, Brown; Animals; Anti-Obesity Agents; Blood Glucose; Body Composition; Body Fat Distribution; Body Temperature; Bupropion; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Eating; Energy Metabolism; Gastroplasty; Glucose Intolerance; Injections, Subcutaneous; Insulin Resistance; Laparoscopy; Male; Naltrexone; Obesity; Physical Conditioning, Animal; Rats, Sprague-Dawley; Thermogenesis; Thyroxine; Weight Loss | 2017 |
No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study.
Topics: Controlled Before-After Studies; Dose-Response Relationship, Drug; Female; Humans; Hypothyroidism; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Prognosis; Thyroid Hormones; Thyroxine; Triiodothyronine | 2020 |